Pegfilgrastim

In the US, Pegfilgrastim (pegfilgrastim systemic) is a member of the drug class colony stimulating factors and is used to treat Neutropenia Associated with Chemotherapy.

US matches:

• Pegfilgrastim


• Pegfilgrastim Subcutaneous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L03AA13

CAS registry number (Chemical Abstracts Service)

0020825-92-3

Chemical Formula

C849-H1347-N223-O244-S9·(C2-H4-0)n

Therapeutic Categories

Immunomodulator

Colony stimulating factor, granulocyte, G-CSF

Chemical Name

Colony-stimulating factor (human), 3-hydroxypropyl-N-methionyl-, 1-ether with alpha-methyl-omega-hydroxypoly(oxy-1,2-ethanediyl)

Foreign Names

• Pegfilgrastimum (Latin)
• Pegfilgrastim (German)
• Pegfilgrastime (French)
• Pegfilgrastim (Spanish)

Generic Names

• Pegfilgrastim (OS: BAN)
• Filgrastim SD01 (IS)
• G-CSF (IS)
• GM-CSF (IS)
• PEG-GCS (IS)
• PEG-granulocyte-colony stimulating factor (IS)
• rhG-CSF (IS)
• rhGM-CSF (IS)
• SD 01 (IS)
• SD Neupogen (IS)

Brand Names

• Jiexin
  Zhongkai, China



• Jimuxin
  NCPC GeneTech, China



• Neulasta
  Amgen, Austria; Amgen, Australia; Amgen, Belgium; Amgen, Czech Republic; Amgen, Germany; Amgen, Spain; Amgen, Finland; Amgen, France; Amgen, United Kingdom; Amgen, Hungary; Amgen, Ireland; Amgen, Iceland; Amgen, Italy; Amgen, Luxembourg; Amgen, Netherlands; Amgen, Norway; Amgen, Poland; Amgen, Portugal; Amgen, Sweden; Amgen, Slovenia; Amgen, Slovakia; Amgen, United States; Amgen Switzerland, Switzerland; Genesis, Greece; Amgen Europe B.VNL, Denmark



• Neulastim
  Roche, Colombia; Roche, Croatia (Hrvatska); Roche, Indonesia; Roche, Israel; Roche, Mexico; Roche, New Zealand; Roche, Oman; Roche, Venezuela; Roche RX, Singapore



• Neupopeg
  Dompe, Slovakia; Dompé Biotec, Italy



• Peglasta
  Roche Switzerland, Singapore

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.